Latest news with #DaiichiSankyoCompany
Business Insider
4 days ago
- Business
- Business Insider
Daiichi Sankyo Company (DSKYF) Receives a Buy from Bernstein
Bernstein analyst Miki Sogi maintained a Buy rating on Daiichi Sankyo Company (DSKYF – Research Report) yesterday and set a price target of Yen6,400.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Sogi is an analyst with an average return of -1.9% and a 45.45% success rate. Sogi covers the Healthcare sector, focusing on stocks such as Daiichi Sankyo Company, Astellas Pharma, and Chugai Pharmaceutical Co. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Daiichi Sankyo Company with a $40.43 average price target. The company has a one-year high of $44.64 and a one-year low of $20.15. Currently, Daiichi Sankyo Company has an average volume of 76.67K.
Business Insider
5 days ago
- Business
- Business Insider
Morgan Stanley Remains a Buy on Daiichi Sankyo Company (DSKYF)
Morgan Stanley analyst Shinichiro Muraoka maintained a Buy rating on Daiichi Sankyo Company (DSKYF – Research Report) yesterday and set a price target of Yen4,750.00. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Muraoka covers the Healthcare sector, focusing on stocks such as Astellas Pharma, Daiichi Sankyo Company, and Shionogi & Co. According to TipRanks, Muraoka has an average return of -3.9% and a 33.33% success rate on recommended stocks. In a report released yesterday, J.P. Morgan also maintained a Buy rating on the stock with a Yen4,700.00 price target.
